European Commission
In this webinar you will learn:
- Simple alternatives to traditional conjoint methods that handle complex product profiles much more effectively
- Alternative approaches that require smaller sample sizes
- Leveraging the vast repository of over $50 million worth of published pharma conjoint studies
- Why (unfortunately) you cannot survey ChatGPT instead of doing conjoints (Harvard academics have tried!)
Please accept {{cookieConsents}} cookies to view this content